July 12, 2012, Parsippany, NJ, USA – The STA® – Rivaroxaban Calibrator and Controls are highly specific, automation-ready products for determining the rivaroxaban concentration in plasma when used in conjunction with the STA® - Liquid Anti-Xa assay. This method was shown to have favorable performance with respect to its linearity and coefficient of variation (CV) in a recent publication.1
June 29, 2012, Parsippany, NJ, USA – Diagnostica Stago, Inc. announces products to suit a variety of clinical research needs for factor VII (FVII). Factor VII is a zymogen that upon activation to its active form, factor VIIa (FVIIa) together with Tissue Factor (TF) comprises the first step in the extrinsic pathway of blood coagulation leading to thrombin formation and subsequent formation of the fibrin clot. Fibrin...
Diagnostica Stago, Inc., (DSI) is an industry leader in the science of hemostasis and thrombosis. Stago provides the total commitment of global resources and responsiveness, coupled with cutting edge technology and reliability. DSI is dedicated to continually developing and providing the very best hemostasis products, technical support, and services.
At Stago, we work hard everyday to ensure we are providing best-in-class products and services for the benefit of our laboratory professional customers and the hemostasis community. We consistently improve our products and services to meet the demands of the ever changing laboratory landscape. Stago is proud to announce that for the second year in a row it has won the Northface Award for Customer Service Excellence by the Omega Management Group.
November 17, 2013
December 7 - 10, 2013
Did you know?
Factor VII and Protein C are the first factors decreased by the antivitamin K treatment (half-life : 4-6 hours).